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Abstract
Introduction: The current study aimed to assess the reliability, validity and psychometric
properties of the Greek translation of the Zung Depression Rating Scale (ZDRS).
Methods: The study sample included 40 depressed patients 29.65 ± 9.38 years old and 120 normal
comparison subjects 27.23 ± 10.62 years old. In 20 of them (12 patients and 8 comparison subjects)
the instrument was re-applied 1–2 days later. Translation and Back Translation was made. Clinical
Diagnosis was reached by consensus of two examiners with the use of the SCAN v.2.0 and the
IPDE. Statistical Analysis included ANOVA, the Pearson Product Moment Correlation Coefficient,
Principal Components Analysis and Discriminant Function Analysis and the calculation of
Cronbach's alpha (α)
Results: Both Sensitivity and specificity exceed 90.00 at 44/45, Chronbach's alpha for the total
scale was equal to 0.09, suggesting that the scale covers a broad spectrum of symptoms. Factor
analysis revealed five factors (anxiety-depression, thought content, gastrenterological symptoms,
irritability and social-interpersonal functioning). The test-retest reliability was satisfactory
(Pearson's R between 0.92).
Conclusion: The ZDRS-Greek translation is both reliable and valid and is suitable for clinical and
research use with satisfactory properties. Its properties are similar to those reported in the
international literature, although the literature is limited. However one should always have in mind
the limitations inherent in the use of self-report scales.
Background
The Zung Depression Rating Scale (ZDRS) [1] is a self-re-
porting instrument and was originally developed in order
to assess depression symptoms without the bias of an ad-
ministrator affecting the results. The items in the ZDRS
scale may also help patients begin to discuss previously
nebulous symptoms, especially those patients who
present with physical symptoms of depression such as
headache or insomnia.
Published: 29 October 2001
BMC Psychiatry 2001, 1:6
Received: 9 September 2001
Accepted: 29 October 2001
This article is available from: http://www.biomedcentral.com/1471-244X/1/6
© 2001 Fountoulakis et al; licensee BioMed Central Ltd. Verbatim copying and redistribution of this article are permitted in any medium for any non-
commercial purpose, provided this notice is preserved along with the article's original URL. For commercial use, contact info@biomedcentral.comPage 1 of 8
(page number not for citation purposes)
BMC Psychiatry 2001, 1 http://www.biomedcentral.com/1471-244X/1/6The ZDRS is a well-known and world-widely used self-rat-
ing scale for the measurement of depression. Along with
the Beck Depression Inventory [2] and the CES-D[3,4]
these are the most popular self-administered instruments
for the assessment of depression. They are supposed to be
used as screening tools rather and not substitutes for an
in-depth interview [5]. They can also be an efficient tool
for screening patients for depression [6] and have been
used successfully for many years in the primary care set-
ting. Higher scores on this scale are indicative of more se-
vere depression [7]
ZDRS consists of 20 items that cover affective, psycholog-
ical, and somatic symptoms. The patient specifies the fre-
quency with which the symptom is experienced (that is: a
little = 1, some = 2, a good part of the time = 3, or most of
the time = 4) [8].
Except from the use of the raw ZDRS score, another way to
rate is the SDS index, which is obtained by dividing the
ZDRS raw score with 80, which is the maximum score.
Minimum score is 20. It is expected that most people with
depression score above 50 (SDS index 0.62). A subject
with ZDRS score below 50 is considered normal, with a
score of 50–59 (SDS 0.62–0.74) is considered to suffer
from mild depression, with score 60–69 (SDS 0.75–0.86)
depression is considered moderate to marked, while with
a score of 70 or above depression is considered to be se-
vere.
The aim of the current study was to assess the reliability,
validity and psychometric properties of the Greek transla-
tion of the Zung Depression Rating Scale
Material and methods
Material
Forty patients (25 males and 15 females) aged 29.65 ±
9.38 years (range 18–55) suffering from Major Depressive
disorder according to DSM-IV [9] and depression accord-
ing to ICD-10 criteria [10], and 120 normal comparison
subjects (71 males and 49 females aged 27.23 ± 10.62
years (range 18–51) entered the study. In 20 of them (12
patients and 8 normal comparison subjects) the instru-
ment was re-applied 1–2 days later.
Patients and normal comparison subjects were free of any
medication for at least two weeks and were physically
healthy with normal clinical and laboratory findings
(Electroencephalogram, blood and biochemical testing,
thyroid function, test for pregnancy, 12 and folic acid).
Patients came from the inpatient and outpatient unit of
the 3rd Department of Psychiatry, Aristotle University of
Thessaloniki, General Hospital AHEPA, Thessaloniki,
Greece. They were consecutive cases and were chosen be-
cause they fulfilled the above criteria.
The normal comparison group was composed of mem-
bers of the hospital staff and relatives of patients. A clini-
cal interview confirmed that they did not suffer from any
mental disorder and their prior history was free from
mental and thyroid disorder.
All patients and normal comparison subjects provided
written informed consent before participating in the
study.
Note: the study sample was identical with that used for the
CES-D standardization study[4]
Method
Translation and back translation was made by two of the
authors, one of whom did not knew the original English
text. The final translation was fixed by consensus.
Clinical diagnosis was reached by consensus of two ex-
aminers. The Schedules for Clinical Assessment in Neu-
ropsychiatry (SCAN) version 2.0 [11,12] and the
International Personality Disorders Examination (IPDE)
[13–15] were used. Both were applied by one of the au-
thors (KNF) who has official training in a World Health
Organization Training and Reference Centre. The IPDE
did not contribute to the clinical diagnosis of depression,
but was used in the frame of a global and comprehensive
assessment of the patients. The second examiner per-
formed an unstructured interview.
Procedure
The identification of potential cases and normal compar-
ison subjects was done first and subjects were referred for
detailed evaluation. The use of structured interviews and
the final consensus decision of the two examiners deter-
mined which subjects would be included in the study.
Testing with the ZDRS followed.
Statistical analysis
Analysis of Variance (ANOVA) [16] was used to search for
differences between groups. The Pearson Product Mo-
ment Correlation Coefficient R was calculated to assess
the test-retest reliability. Principal Components Analysis
(Varimax Normalized Rotation) was performed, and fac-
tor coefficients and scores were calculated. Finally, Discri-
minant Function Analysis was performed as well.
Item Analysis [17] was performed, and the value of Cron-
bach's alpha (α) for ZDRS and its factor subscales was cal-
culated. Receiver Operator Characteristic Curves (ROC
curves) and histogram of frequencies were created as well.Page 2 of 8
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The calculation of sensitivity (Sn) and specificity (Sp) at
various cut-off levels showed that both variables exceed
90.00 at 44/45 (SDS 0.55/0.56), with 111 normal com-
parison subjects and 36 patients correctly classified. Nine
9 normal comparison subjects and 4 patients were classi-
fied into a wrong diagnostic group (table 1). Receiver Op-
eration Curve Analysis (figure 1) confirmed these results.
Chronbach's alpha for the total scale was equal to 0.09,
and this is a very low value, suggesting that the scale cov-
ers a broad spectrum of symptoms and represents a global
assessment of depression.
The histogram of ZDRS scores in normal comparison sub-
jects reveals that they do not follow the normal distribu-
tion in this population, but manifest a skewness towards
lower values (figure 2).
The factor analysis of cases (varimax normalized rotation)
revealed five factors (table 2). The first one explained 15%
of total variance, included items No 1, 2, 4, 9 and 10 and
largely reflects a factor of anxiety-depression. The second
one explained 16% of total variance, included items No
11, 12, 14, 16, 17, 18 and 20 and largely reflects a cogni-
tive (thought content) factor. The third factor explained
11% of total variance, included items No 5, 7 and 8 and
reflects gastrenterological symptoms. The fourth ex-
plained 10% of total variance, included items No 11, 12
and 15 and represents an aspect of symptomatology sim-
ilar with factor 2, with the addition of irritability. The last
factor explained 13% of total variance, included items No
3, 6, 10 and 19 and reflects social and interpersonal func-
tioning. Factor loadings and coefficients are shown in ta-
ble 2. All five factors explained 64% of total ZDRS
variance.
Chronbach's alpha for the individual factors (subscales
that include the items that load in each one) was fair, with
values from 0.23 to 0.45. Only factor 2 had high internal
consistency with alpha equal to 0.86.
Depressed patients did not differ from normal compari-
son subjects in age. On the contrary they differed in every
ZDRS individual item score and total score (p < 0.001 –
table 3). It is very interesting that the two groups differed
in the scores of factors 1, 3 and 5 (p < 0.001), that is in the
essence of anxiety, depression, gastrenterological symp-
toms, and social and interpersonal functioning, but not in
the score of factors 2 and 4, that is thought content and ir-
ritability.
The test-retest reliability proved to be satisfactory. Individ-
ual items had good Pearson correlation coefficients with
lower for item No 6 (R = 0.51) and higher for item No 7
(R = 0.89). The coefficient for the total ZDRS score was ex-
cellent and equal to 0.92.
Discriminant function analysis results are shown in table
4. Two separate analyses were performed, with the for-
ward stepwise method, one with individual ZDRS items
and a second with factor scores. The first one performed
excellently while the second one was fair. The results of
the first one suggest that when the D-C equation, that is:
2.65*(itl) - 0.45*(it2) + 2.03*(it3) + 1.14*(it4) -
0.97*(it6) + 1.56*(it7) + 0.82*(it8) + 1.18*(it9) +
1.13*(it10) + 1.02*(it11) - 2.37*(it12) - 1.46*(it15) +
0.91*(itl6) + 0.97*(itl7) takes values above 15.52, then
the subject is a depressed patient. This method correctly
classified all normal comparison subjects and 90% of pa-
tients.
Figure 1
ROC analysis Curve-the score level 44/45 has the largest dis-
tance from the dichotomous
Table 1: Sensitivity and Specificity of ZDRS at various cut-off lev-
els. The optimum is at level 44/45
ZUNG
level tn fp fn tp Sn Sp
41/42 103 17 2 38 95.00 85.83
42/43 105 15 3 37 92.50 87.50
43/44 107 13 3 37 92.50 89.17
44/45 111 9 4 36 90.00 92.50
45/46 112 8 7 33 82.50 93.33
46/47 112 8 9 31 77.50 93.33
47/48 114 6 10 30 75.00 95.00
48/49 114 6 10 30 75.00 95.00
49/50 114 6 10 30 75.00 95.00
50/51 114 6 11 29 72.50 95.00Page 3 of 8
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Self-administered scales heavily depend on the co-opera-
tion and reading ability of the patient. On the other hand
they save time for the clinician. More, translations are dif-
ficult to access because of publication in various languag-
es or national journals [18–21].
The current study reports observations on the reliability,
the validity and psychometric properties of the Greek
translation of the Zung Depression Rating Scale. The re-
sults suggest that this translation is well suited for use in
the Greek population with high sensitivity and specificity
at the cut-off level 44/45 and high test-retest reliability.
The reliability and validity of the Zung Depression Rating
Scale has been examined in only a limited number of
studies and not many translations of this scale have been
published. In the original study [1] this scale was found be
able to differentiate between depressed patients and nor-
mal comparison subjects. Later studies showed the rela-
tionship of the scale with the clinician's assessment of
severity, the Beck Depression Inventory, the D dimension
of the MMPI and an unstable relationship with the Ham-
ilton Depression Rating Scale [22–26].
The highest published cut-point for the ZDRS was 60/61
[27] and with an unusually low sensitivity for detecting
major depression. Other studies generally accept the level
49/50 and report 97% sensitivity and 63% specificity.
In another study, 69 randomly selected medical outpa-
tients were clinically evaluated for depressive illness.
ZDRS identified 30% of those depressed while missing
those whose depression was presented under the guise of
somatic illness [28].
While there are data supporting the content and construct
validity of the ZDRS, the evidence regarding its reliability
Table 2: Factor loadings and coefficients after Factor Analysis (Varimax normalized rotation) of normal comparison subjects and 
patients data
Factor Loadings Factor Coefficients
Factor Factor Factor Factor Factor Factor Factor Factor Factor Factor
Item No 1 2 3 4 5 1 2 3 4 5
1 0.53 -0.30 -0.38 -0.23 0.45 0.12 0.07 -0.08 0.01 0.12
2 -0.59 0.44 0.08 0.03 0.25 -0.32 0.23 -0.06 -0.11 0.38
3 0.27 -0.17 -0.29 -0.07 0.74 -0.03 0.15 -0.06 0.09 0.41
4 0.75 -0.16 -0.07 -0.05 0.14 0.40 0.05 0.10 0.12 -0.07
5 -0.12 0.39 0.66 0.05 -0.12 0.10 0.10 0.38 -0.09 0.09
6 0.03 0.19 0.11 0.40 -0.66 0.24 -0.08 -0.06 0.24 -0.40
7 0.25 -0.24 -0.70 0.29 0.20 0.05 0.01 -0.44 0.37 -0.01
8 0.03 0.05 -0.70 -0.32 0.05 -0.13 0.17 -0.46 -0.16 -0.05
9 0.73 0.01 -0.03 -0.23 0.30 0.36 0.20 0.13 -0.03 0.09
10 0.49 -0.15 -0.26 -0.20 0.46 0.14 0.13 -0.03 0.00 0.18
11 -0.28 0.43 0.33 0.47 -0.12 0.03 0.11 0.07 0.22 0.12
12 -0.26 0.43 0.29 0.43 -0.25 0.06 0.09 0.04 0.20 0.01
13 0.63 -0.13 -0.38 -0.32 0.15 0.24 0.12 -0.12 -0.07 -0.08
14 -0.32 0.51 0.21 0.34 -0.26 0.01 0.15 -0.03 0.12 0.02
15 0.26 -0.14 0.01 -0.72 0.09 0.00 0.03 0.15 -0.47 -0.04
16 -0.21 0.60 0.13 0.29 -0.06 0.04 0.28 -0.06 0.12 0.15
17 0.05 0.79 0.10 -0.02 -0.17 0.18 0.44 -0.05 -0.09 0.06
18 -0.29 0.64 0.21 0.08 -0.41 0.02 0.22 -0.03 -0.09 -0.08
19 0.24 -0.46 0.14 0.31 0.60 0.06 -0.15 0.23 0.33 0.32
20 -0.24 0.51 0.12 0.32 -0.35 0.06 0.15 -0.09 0.13 -0.07
Expl. Var 3.08 3.14 2.22 1.93 2.50
Prp. Totl 15% 16% 11% 10% 13%
Total Var 0.64%
ExplPage 4 of 8
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SDS item No description Mean s.d. Mean s.d. P
Age 29.65 9.38 27.23 10.62 0.233
1 I feel down-hearted and blue 3.08 0.87 1.43 0.59 0.000
Aισθάνoµαι κακóκεφoς και έχω τις µαύρες µoυ
2 Morning is when I feel the best 1.95 1.05 2.76 0.99 0.000
To piρωί αισθάνoµαι καλύτερα
3 I have crying spells or feel like it 2.51 0.85 1.28 0.50 0.000
Kλαίω ή µoύρχεται να κλάψω
4 I have trouble sleeping at night 2.44 1.14 1.32 0.70 0.000
'Eχω piρoβλήµατα µε τoν ύpiνo µoυ τη νύχτα
5 I eat as much as I used to 2.08 0.96 3.07 0.93 0.000
Tρώω óσo έτρωγα συνήθως
6 I enjoy looking at, talking to and being with attractive women/men 2.15 1.16 3.33 0.92 0.000
Moυ αρέσει να κoιτάω, να µιλάω και να βρίσκoµαι µε ελκυστικές
γυναίκες/άνóρες
7 I notice that I am loosing weight 2.28 1.07 1.27 0.56 0.000
Παρατηρώ óτι χάνω βάρoς
8 I have trouble with constipation 1.92 1.20 1.22 0.57 0.000
'Eχω piρóβληµα δυσκoιλιóτητας
9 My heart beats faster than usual 2.28 1.05 1.30 0.51 0.000
H καρδιά µoυ χτυpiά γρηγoρóτερα αpi´ τo συνηθισµένo
10 I get tired for no reason 2.90 1.02 1.47 0.73 0.000
Koυράζoµαι χωρίς να υpiάρχει λóγoς
11 My mind is as clear as I used to be 2.21 0.95 3.20 0.96 0.000
To µυαλó µoυ είναι τóσo καθαρó óσo ήταν piάντα.
12 I find it easy to do the things I used to 1.56 0.64 3.15 0.97 0.000
Moυ είναι εύκoλo να κάνω τα piράγµατα pioυ piάντα έκανα
13 I am restless and can't keep still 2.77 0.90 1.61 0.79 0.000
Eιµαιαν ήσυχoς και δε µpioρώ να καθήσω ακίνητoς.
14 I feel hopeful about the future 1.87 0.92 3.18 1.00 0.000
Aισθάνoµαι αισιóδoξα για τo µέλλoν
15 I am more irritable than usual 7.38 0.96 1.87 0.94 0.003
Eίµαιpiερι σσδτερo ευερέθιστoζ αpió τo συνηθισµένo
16 I find it easy to make decisions 2.08 0.93 2.75 0.96 0.000
To βρίσκω εύκoλo να piαίρνω αpioφάσειζ
17 I feel that I am useful and needed 2.51 1.14 3.00 0.93 0.008
Aισθάνoµαι óτι είµαι Χρήσιµoζ και µε έΧoυν ανάγκη
18 My life is pretty full 1.69 1.00 3.22 0.91 0.000
H ζωή µoυ είναι γεµάτη
19 I feel that others would be better off if I were dead 1.67 0.93 1.07 0.42 0.000
Aισθάνοµαι óτι θα ήταν καλύτερα για τoυζ άλλoυζα νεγώ piέθαινα
20 I still enjoy the things I used to do 1.87 1.13 3.20 0.95 0.000
Aκóµα αpioλαµβάνω τα piράγµατα pioυ συνήθιζα να κάνω.
ZDRS score 54.26 8.97 32.98 7.88 0.000
Fact 1 score Anxious and depressed affect 0.71 1.34 -0.24 0.72 0.000
Fact 2 score Thought content -0.20 0.97 0.07 1.00 0.135
Fact 3 score Gastrenterological problems -0.54 1.39 0.18 0.76 0.000
Fact 4 score Irritability -0.34 1.17 0.11 0.92 0.012
Fact 5 score Social Functioning 0.63 1.28 -0.21 0.79 0.000Page 5 of 8
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metric properties of the ZDRS, two studies were done us-
ing subjects from two markedly different socio-cultural
settings: 213 male and female drug addicts in New York
City and 206 male and female undergraduates in Nigeria.
Findings included high coefficient alphas and large aver-
age item-correlations (total minus item) in both studies.
It was concluded that the ZDRS rates well in terms of in-
ternal consistency reliability and construct validity [29].
Using both the English version and an Igbo translation of
ZDRS in 132 first-time attenders to a hospital-based gen-
Table 4: Discriminant Function Analysis Results.
A
Classification Functions Classification Matrix
SDS item No normal depressed D-C Rows: Observed classifications
comparison
subjects
Constant -47.84 -63.36 -15.52 Columns: Predicted classifications
Item No 1 4.50 7.15 2.65 % normal depressed
Correct comparison
subjects
Item No 2 2.32 1.87 -0.45 Comp subjects 100.00 120 0
Item No 3 4.05 6.08 2.03 depressed 90.00 4 36
Item No 4 3.10 4.24 1.14 Total 97.50 124 36
Item No 6 3.00 2.03 -0.97
Item No 7 3.19 4.74 1.56
Item No 8 3.32 4.14 0.82
Item No 9 1.35 2.53 1.18
Item No 10 2.04 3.17 1.13
Item No 11 4.46 5.48 1.02
Item No 12 3.12 0.75 -2.37
Item No 15 4.59 3.12 -1.46
Item No 16 2.06 2.98 0.91
Item No 17 0.02 0.99 0.97
B
Classification Functions Classification Matrix
Factor No normal depressed D-C Rows: Observed classifications
comparison
subjects
Constant -0.42 -2.63 -2.21 Columns: Predicted classifications
Factor 1 -0.43 1.30 1.72 % normal depressed
Correct comparison
subjects
Factor 2 0.12 -0.37 -0.49 Comp subj 95.00 114 6
Factor 3 0.32 -0.98 -1.30 depressed 72.50 11 29
Factor 4 0.21 -0.62 -0.83 Total 89.38 125 35
Factor 5 -0.38 1.15 1.53
Analysis with individual ZDRS items entering the procedure. When the equation: 2.65*(itl) - 0.45*(it2) + 2.03*(it3) + 1.14*(it4) - 0.97*(it6) + 
1.56*(it7) + 0.82*(it8) + 1.18*(it9) + 1.13*(it10) + 1.02*(itll) - 2.37*(it12) - 1.46*(it15) + 0.91*(itl6) + 0.97** itl7) > 15.52 is true, then the subject is 
a depressed patient. This method correctly classified all normal comparison subjects and 90% of patients. B: Analysis with factor scores entering the 
procedure. When the equation: 1.72*(f1) - 0.49*(f2) - 1.3*(f3) - 0.83*(f4) + 1.53*(f5) > 2.21 is true, then the subject is a depressed patient. This 
method correctly classified 95% of normal comparison subjects and 72.5% of patientsPage 6 of 8
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sive symptoms was obtained. Fourteen percent scored
within the range for "mild depression", while 11% ob-
tained scores within the range for "moderate depression"
[30].
Review studies on various self-administered instruments
suggest that there is no significant difference between var-
ious self-administered depressive scales in terms of per-
formance. Overall sensitivity is around 84% and
specificity around 72% [31]. These instruments are of par-
ticular value in primary care settings because it is clear that
primary care providers fail to diagnose and treat as many
as 35% to 50% of patients with depressive disorders
[32,33]. Depression is one of the most common psychiat-
ric diagnoses in primary care populations [34]; major de-
pressive disorders can be diagnosed in 6% to 9% of such
patients. Obstacles to the appropriate recognition of de-
pression include inadequate provider knowledge of diag-
nostic criteria; competing comorbid conditions and
priorities among primary care patients; time limitations in
busy office settings; concern about the implications of la-
beling; poor reimbursement mechanisms; and uncertain-
ty about the value, accuracy, and efficiency of screening
mechanisms for identifying patients with depression. Giv-
en that 50% to 60% of persons seeking help for depres-
sion are treated exclusively in the primary care setting,
accurate detection in this setting is important [35] and self
– administered instruments may help to ameliolate some
of them. Many studies have assessed the effect of feedback
of scale scores on physician practice patterns [36–45] and
have shown improved recognition of depression with
such feedback.
On the other hand, it should be noted that the diagnosis
of depression is itself based on symptoms. A patient can-
not truly be asymptomatic and have major depressive dis-
order. Thus, these screening questionnaires are actually
being evaluated for their ability to detect unrecognized,
rather than strictly asymptomatic, depressive symptoms
and disease.
The Canadian Task Force on the Periodic Health Examina-
tion found fair evidence to exclude the use of depression
detection tests from the periodic health examination of
asymptomatic people [46]. The American Academy of
Family Physicians advises physicians to remain alert for
depressive symptoms in adolescents and adults [47]; this
policy is under review. The American Medical Association
recommends that all adolescents be asked annually about
behaviors or emotions that indicate recurrent or severe de-
pression [48].
Conclusion
The Greek translation of the ZDRS scale is both reliable
and valid and is suitable for clinical and research use with
satisfactory properties. However one should always have
in mind the limitations inherent in the use of self-report-
ing scales.
The very low internal consistency of the scale, reported by
the current study suggests that the ZDRS is not a unidi-
mensional scale. It is also evident that its development
was not based on the contemporary definition of depres-
sion but rather on that of the sixties. Thus, although sen-
sitivity and specificity were proved to be high, the




1. Zung WWK: A Self-Rating Depression Scale. Arch Gen Psychiatry
1965, 12:63-70
2. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An Inventory
for Measuring Depression. Arch Gen Psychiatry 1961, 4:53-63
3. Radloff LS: The CES-D scale: A self report depression scale for
research in the general population. Applied Psychological Measure-
ment 1977, 1:385-401
4. Fountoulakis KN, lacovides A, Kleanthous S, Samolis S, Kaprinis SG,
Sitzoglou K, Kaprinis GS, Per Bech: Reliability, Validity and Psy-
chometric Properties of the Greek Translation of the Cent-
er for Epidemiological Studies-Depression (CES-D) Scale.
BMC Psychiatry 2001, 1(1):3
5. Zung WW, Richards CB, Short MJ: Self-rating depression scale in
an outpatient clinic. Further validation of the SDS. Arch Gen
Psychiatry 1965 Dec, 13(6):508-515
6. Carrell BJ: Validity of the Zung self-rating scale. Br J Psychiatry
1978 Oct, 133:379-380
7. Marder SR: Psychiatric rating scales. In: Kaplan HI, Sadock BJ,
eds. Comprehensive Textbook of Psychiatry/VI 6th ed. Balti-
more, Md: Williams & Wilkins; 1995, 1:619-635
8. Carroll BJ, Fielding JM, Blashki TG: Depression rating scales: a
critical review. Arch Gen Psychiatry 1973, 28:361-366
9. American Psychiatric Association: Diagnostic and Statistical
Manual of Mental Disorders, 41 Edition, DSM-IV. American Psy-
chiatric Press, Washington DC 1994
10. World Health Organisation: The ICD-10 Classification of Mental
and Behavioural Disorders. Diagnostic Criteria for Research. Geneva,
199381-87
Figure 2
Histogram of ZDRS scores in Control subjectsPage 7 of 8
(page number not for citation purposes)
BMC Psychiatry 2001, 1 http://www.biomedcentral.com/1471-244X/1/6Publish with BioMed Central  and  every 
scientist can read your work free of charge
"BioMedcentral will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Paul Nurse, Director-General, Imperial Cancer Research Fund
Publish with BMC and your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours - you keep the copyright
editorial@biomedcentral.com
Submit your manuscript here:
http://www.biomedcentral.com/manuscript/
BioMedcentral.com
11. Wing JK, Babor T, Brugha T, et al: SCAN: Schedules for Clinical
Assessment in Neuropsychiatry. Archives of General Psychiatry,
1990, 47:589-593
12. World Health Organisation: Schedules for Clinical Assessment
in Neuropsychiatry – SCAN version 2.0) Greek Version: Ma-
vreas V. Research University Institute for Mental Health, Athens 1995
13. Loranger AW, Sartorious N, Andreoli A, et al: The World Health
Organisation/Alcohol, Drug Abuse and Mental Health Ad-
ministration International Pilot Study of Personality Disor-
ders. Archives of General Psychiatry, 1994, 51:215-224
14. World Health Organisation: International Personality Disorders
Examination, Geneva, 1995
15. World Health Organisation: International Personality Disorders
Examination, Greek Edition. (Translation: Fountoulakis KN, lacov-
ides A, Kaprinis G, lerodiakonou Ch) 3rd Department of Psychiatry, Aristotle
University of Thessaloniki Greece (unpublished) 
16. Altman DG: Practical Statistics for Medical Research. Chapman
and Hall, London 1991
17. Anastasi A: Psychological Testing 6th edition. Macmillan Publish-
ing Company, New York, 1988202-234
18. Lopez VC, de Esteban Chamorro T: [Validity of Zung's Self-Rat-
ing Depression Scale]. [Article in Spanish] Arch Neurobiol (Madr)
1975 May-Jun, 38(3):225-46
19. Xu MY: [Using the SDS (self-rating depression scale) for ob-
servations on depression]. [Article in Chinese] 1987 Apr,
22(4):156-159
20. Chen XS: [Masked depression among patients diagnosed as
neurosis in general hospitals]. [Article in Chinese] 1986 Jan,
66(1):32-33
21. Jegede RO: Psychometric characteristics of Yoruba versions
of Zung's self-rating depression scale and self-rating anxiety
scale. Afr J Med Med Sci 1979 Sep-Dec, 8(3-4):133-137
22. Zung WWK: Factors Influencing the Self-Rating Depression
Scale. Arch Gen Psychiatry, 1967, 16:543-547
23. Brown GL, Zung WWK: Depression Scales. Compr Psychiatry,
1972, 13:361-367
24. Davies B, Burrows G, Paynton C: A Comparative Study of Four
Depression Rating Scales. Austr NZ J Pzychiatry, 1975, 9:21-24
25. Carroll BJ, Fielding JM, Blashki MB: Depression Rating Scales: A
Critical Review. Arch Gen Psychiatry, 1973, 28:361-366
26. Biggs JT, Wylie LT, Ziegler VE: Validity of the Zung Self-rating
Depression Scale. Br J Psychiatry 1978 Apr, 132:381-385
27. Raft D, Spencer RF, Toomey T, Brogan D: Depression in medical
outpatients: use of the Zung scale. Dis Nerv Syst 1977, 38:999-
1004
28. Raft D, Spencer RF, Toomey T, Brogan D: Depression in medical
outpatients: use of the Zung scale. Dis Nerv Syst 1977 Dec,
8(12):999-1004
29. Jegede RO: Psychometric properties of the Self-Rating De-
pression Scale (SDS). J Psychol 1976 May, 93(1st Half):27-30
30. Ihezue UH, Kumaraswamy N: Prevalence of depressive symp-
toms among patients attending a general outpatient clinic.
Acta Psychiatr Scand 1986 Apr, 73(4):395-398
31. Mulrow Cynthia D MD MSc, Williams John W Jr MD MHS, Gerety
Meghan B MD, Ramirez Gilbert DrPH, Montiel Oscar M MD, Kerber
Caroline MD: Case-Finding Instruments for Depression in Pri-
mary Care Settings Annals of Internal Medicine, 15 June 1995,
123:913-921
32. Simon GE, VonKorff M: Recognition, management, and out-
comes of depression in primary care. Arch Fam Med 1995, 4:99-
105
33. Gerber PD, Barrett J, Barrett J, Manheimer E, Whiting R, Smith R:
Recognition of depression by internists in primary care: a
comparison of internist and gold standard psychiatric assess-
ments. J Gen Intern Med 1989, 4:7-13
34. Katon W, Roy-Byrne PP: Antidepressants in the medically ill: di-
agnosis and treatment in primary care. Clin Chem 1988, 34:829-
836
35. Schurman RA, Krooner PD, Mitchell JB: The hidden mental health
network. Treatment of mental illness by nonpsychiatric phy-
sicians. Arch Gen Psychiatry 1985, 42:89-94
36. Callahan CM, Hendrie HC, Dittus RS, Brater DC, Hui SL, Tierney
WM: Improving treatment of late life depression in primary
care: a randomized clinical trial. J Am Geriatr Soc 1994, 42:840-
845
37. Brody DS, Lerman CE, Wolfson HG, Caputo GC: Improvement in
physicians' counseling of patients with mental health prob-
lems. Arch Intern Med 1990, 150:993-998
38. Magruder-Habib K, Zung WW, Feussner JR: Improving physicians'
recognition and treatment of depression in general medical
care. Med Care 1990, 28:239-250
39. Rand EH, Badger LW, Coggins DR: Toward a resolution of con-
tradictions. Utility of feedback from the GHQ. Gen Hosp Psy-
chiatry 1988, 10:189-196
40. Rucker L, Frye EB, Cygan RW: Feasibility and usefulness of de-
pression screening in medical outpatients. Arch Intern Med
1986, 146:729-731
41. Hoeper EW, Nycz GR, Kessler LG, Burke JD Jr, Pierce WE: The use-
fulness of screening for mental illness. Lancet 1984, 1:33-35
42. Zung WW, King RE: Identification and treatment of masked
depression in a general medical practice. J Clin Psychiatry 1983,
44:365-368
43. Zung WW, Magill M, Moore JT, George DT: Recognition and
treatment of depression in a family medicine practice. J Clin
Psychiatry 1983, 44:3-6
44. Johnstone A, Goldberg D: Psychiatric screening in general prac-
tice. A controlled trial. Lancet 1976, 1:605-608
45. Magruder-Habib K, Zung WWK, Feussner JR: Improving physi-
cians' recognition and treatment of depression in general
medical care: results from randomized clinical trial. Med Care
1990, 28:239-250
46. Canadian Task Force on the Periodic Health Examination: Canadian
guide to clinical preventive health care. Ottawa: Canada Com-
munication Group, 1994450-455
47. American Academy of Family Physicians: Age charts for periodic
health examination. Kansas City, MO: American Academy of Family
Physicians, 1994. (Reprint no.510.) 
48. American Medical Association: Guidelines for adolescent pre-
ventive services (GAPS): recommendations and rationale.
Chicago: American Medical Association, 1994131-139Page 8 of 8
(page number not for citation purposes)
